EA199600027A2 - Хлоргидрат цилпатерола в особой кристаллизованной форме, способ его получения и используемые промежуточные продукты - Google Patents
Хлоргидрат цилпатерола в особой кристаллизованной форме, способ его получения и используемые промежуточные продуктыInfo
- Publication number
- EA199600027A2 EA199600027A2 EA199600027A EA199600027A EA199600027A2 EA 199600027 A2 EA199600027 A2 EA 199600027A2 EA 199600027 A EA199600027 A EA 199600027A EA 199600027 A EA199600027 A EA 199600027A EA 199600027 A2 EA199600027 A2 EA 199600027A2
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- solution
- temperature
- hydrochloride
- less
- trihydrate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- ZXNVOFMPUPOZDF-UHFFFAOYSA-N 2-(dibenzylamino)-3-phenylpropan-1-ol Chemical compound C=1C=CC=CC=1CN(CC=1C=CC=CC=1)C(CO)CC1=CC=CC=C1 ZXNVOFMPUPOZDF-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 229940084164 zilpaterol hydrochloride Drugs 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 5
- 239000000243 solution Substances 0.000 abstract 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 3
- 150000004684 trihydrates Chemical class 0.000 abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 238000001816 cooling Methods 0.000 abstract 2
- 239000013078 crystal Substances 0.000 abstract 2
- 235000019441 ethanol Nutrition 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 1
- 210000002257 embryonic structure Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 238000001953 recrystallisation Methods 0.000 abstract 1
- 238000009331 sowing Methods 0.000 abstract 1
- 230000002269 spontaneous effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/807—Poultry or ruminant feed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Husbandry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Fodder In General (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к безводному хлоргидрату цилпатерола в кристаллизованной форме, содержащему менее 5% кристаллов размером менее 15 мкм, а размер остальных кристаллов составляет менее 250 мкм, и вариантам способа его получения. Первый вариант способа заключается в получении при температуре более 50°С перенасыщенного раствора хлоргидрата цилпатерола в воде или смеси воды и этилового спирта, охлаждении раствора для кристаллизации моногидрата с последующим снижением температуры раствора до уровня ниже 20°С для кристаллизации тригидрата и высушивании полученного продукта. Второй вариант способа предусматривает получение при температуре менее 30°С насыщенного водного раствора хлоргидрата цилпатерола с последующей спонтанной рекристаллизацией тригидрата. Третий вариант способа предусматривает получение насыщенного водного-спиртового раствора хлоргидрата цилпатерола, его охлаждение до температуры менее 20°С и засеивание зародышами тригидрата, после чего в подготовленный раствор вносят водный раствор хлоргидрата цилпатерола, полученный при температуре 60-100°С. Полученный продукт используют для приготовления премикса, который добавляют в корм для животных.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9506966A FR2735474B1 (fr) | 1995-06-13 | 1995-06-13 | Chlorhydrate de zilpaterol sous une forme cristallisee particuliere, son procede de preparation et les produits intermediaires mis en oeuvre |
Publications (3)
Publication Number | Publication Date |
---|---|
EA199600027A2 true EA199600027A2 (ru) | 1996-12-30 |
EA199600027A3 EA199600027A3 (ru) | 1997-03-31 |
EA000011B1 EA000011B1 (ru) | 1997-12-30 |
Family
ID=9479897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199600027A EA000011B1 (ru) | 1995-06-13 | 1996-06-11 | Безводный хлоргидрат цилпатерола в кристаллизованной форме, способ его получения (его варианты), моногидрат и тригидрат хлоргидрата цилпатерола в качестве промежуточных продуктов |
Country Status (21)
Country | Link |
---|---|
US (2) | US5731028A (ru) |
EP (1) | EP0753518B1 (ru) |
JP (1) | JP4249273B2 (ru) |
KR (1) | KR100395204B1 (ru) |
CN (2) | CN1083244C (ru) |
AT (1) | ATE196471T1 (ru) |
AU (1) | AU701653B2 (ru) |
BR (1) | BR9602788A (ru) |
CA (1) | CA2178783C (ru) |
DE (1) | DE69610374T2 (ru) |
DK (1) | DK0753518T3 (ru) |
EA (1) | EA000011B1 (ru) |
ES (1) | ES2151999T3 (ru) |
FR (1) | FR2735474B1 (ru) |
GR (1) | GR3034458T3 (ru) |
HU (1) | HU220461B1 (ru) |
IN (1) | IN2014DE02233A (ru) |
MX (1) | MX9602307A (ru) |
PT (1) | PT753518E (ru) |
UA (1) | UA48941C2 (ru) |
ZA (1) | ZA964977B (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4956308A (en) * | 1987-01-20 | 1990-09-11 | Itt Corporation | Method of making self-aligned field-effect transistor |
KR100344157B1 (ko) * | 2000-01-06 | 2002-07-31 | 주식회사 하이테크 그라스 | 배경무늬 형성을 위한 장식판 도포제재 및 장식판의배경무늬 형성방법 |
US7207289B2 (en) * | 2004-05-20 | 2007-04-24 | Intervet International B.V. | Method of feeding the cattle with feed additives that increases beef production and reduces liver abscess |
JP5126626B2 (ja) | 2007-02-01 | 2013-01-23 | インターベツト・インターナシヨナル・ベー・ベー | 6−アミノ−7−ヒドロキシ−4,5,6,7−テトラヒドロ−イミダゾ[4,5,1−jk][1]−ベンゾアゼピン−2[1h]−オンおよびジルパテロールのエナンチオ選択的合成 |
HK1136565A1 (en) * | 2007-03-31 | 2010-07-02 | Intervet Int Bv | Processes for making zilpaterol and salts thereof |
SG10201405734UA (en) | 2007-03-31 | 2014-10-30 | Intervet Int Bv | Processes For Making Zilpaterol And Salts Thereof |
US8362006B2 (en) * | 2007-03-31 | 2013-01-29 | Intervet International B.V. | Processes for making zilpaterol and salts thereof |
CA2708044C (en) | 2007-12-06 | 2017-01-03 | Mary Irene Wray | Combination therapies using melengestrol acetate and zilpaterol or its salts |
TW201033217A (en) * | 2008-12-17 | 2010-09-16 | Intervet Int Bv | Process for making a crystalline zilpaterol salt |
RU2635695C2 (ru) | 2012-05-18 | 2017-11-15 | Интервет Интернэшнл Б.В. | Способ усиления прироста кур-бройлеров |
MX361888B (es) | 2012-12-18 | 2018-12-17 | Intervet Int Bv | Un procedimiento mejorado para producir zilpaterol. |
MX2015012726A (es) | 2013-03-15 | 2016-02-18 | Intervet Int Bv | Metodo para mejorar la eficiencia de la produccion de carne de animales bovinos. |
US9364483B2 (en) | 2014-06-20 | 2016-06-14 | Laboratorios Virbac | Pre-mix composition for cattle |
CN105334323A (zh) * | 2014-08-07 | 2016-02-17 | 暨南大学 | 一种检测齐帕特罗的方法和试纸条及其应用 |
US10231472B2 (en) | 2015-07-21 | 2019-03-19 | Intervet Inc. | Zilpaterol animal premix formulation |
EP3488705A1 (en) | 2017-11-23 | 2019-05-29 | Saviela AG | Solubilized growth promoting product to be applied orally to animals and method for the respective feed preparation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534257A1 (fr) * | 1982-10-12 | 1984-04-13 | Roussel Uclaf | Nouveaux derives de la 6-amino 7-hydroxy 4,5,6,7-tetrahydro-imidazo/4,5,1-j-k/ /1/ benzazepin-2(1h)-one, leurs sels, application a titre de medicaments, compositions les renfermant et un intermediaire |
US4497779A (en) * | 1983-10-14 | 1985-02-05 | Amax Inc. | Production of potassium hexafluotitanates using dilute hydrofluoric acid |
IE60588B1 (en) * | 1986-07-30 | 1994-07-27 | Sumitomo Pharma | Carbapenem compound in crystalline form, and its production and use |
IE60964B1 (en) * | 1986-12-11 | 1994-09-07 | Roussel Uclaf | Zootechnical compositions containing a beta-adrenergic |
FR2608046B1 (fr) * | 1986-12-11 | 1989-03-31 | Roussel Uclaf | Compositions zootechniques renfermant un derive de la 6-amino 7-hydroxy 4,5,6,7-tetrahydroimidazo /4,5, 1-j-k/ /1/benzazepin-2-(1h)-one |
US5015639A (en) * | 1987-03-27 | 1991-05-14 | Schering Corporation | Substituted benzazepines, their preparation and pharmaceutical compositions containing them |
FR2647310B1 (fr) * | 1989-05-29 | 1992-01-17 | Roussel Uclaf | Utilisation de beta-adrenergiques pour la fabrication de compositions zootechniques |
US5629308A (en) * | 1992-12-04 | 1997-05-13 | Janssen Pharmaceutica N.V. | Imidazo [1,2-A] (pyrrolo, thieno or furano) [2,3-D] azepine derivatives |
-
1995
- 1995-06-13 FR FR9506966A patent/FR2735474B1/fr not_active Expired - Lifetime
-
1996
- 1996-06-06 US US08/659,367 patent/US5731028A/en not_active Expired - Lifetime
- 1996-06-10 UA UA96062282A patent/UA48941C2/ru unknown
- 1996-06-11 EP EP96401252A patent/EP0753518B1/fr not_active Expired - Lifetime
- 1996-06-11 ES ES96401252T patent/ES2151999T3/es not_active Expired - Lifetime
- 1996-06-11 AT AT96401252T patent/ATE196471T1/de active
- 1996-06-11 PT PT96401252T patent/PT753518E/pt unknown
- 1996-06-11 DK DK96401252T patent/DK0753518T3/da active
- 1996-06-11 CA CA002178783A patent/CA2178783C/fr not_active Expired - Lifetime
- 1996-06-11 DE DE69610374T patent/DE69610374T2/de not_active Expired - Lifetime
- 1996-06-11 EA EA199600027A patent/EA000011B1/ru not_active IP Right Cessation
- 1996-06-12 ZA ZA964977A patent/ZA964977B/xx unknown
- 1996-06-12 JP JP17166996A patent/JP4249273B2/ja not_active Expired - Lifetime
- 1996-06-12 AU AU55925/96A patent/AU701653B2/en not_active Expired
- 1996-06-12 MX MX9602307A patent/MX9602307A/es unknown
- 1996-06-12 CN CN96110424A patent/CN1083244C/zh not_active Expired - Lifetime
- 1996-06-12 KR KR1019960020901A patent/KR100395204B1/ko not_active IP Right Cessation
- 1996-06-12 HU HU9601617A patent/HU220461B1/hu unknown
- 1996-06-12 CN CNB021030898A patent/CN1164591C/zh not_active Expired - Lifetime
- 1996-06-13 BR BR9602788A patent/BR9602788A/pt not_active Application Discontinuation
-
1997
- 1997-12-11 US US08/989,223 patent/US5847124A/en not_active Expired - Lifetime
-
2000
- 2000-09-21 GR GR20000402058T patent/GR3034458T3/el unknown
-
2014
- 2014-08-06 IN IN2233DE2014 patent/IN2014DE02233A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199600027A2 (ru) | Хлоргидрат цилпатерола в особой кристаллизованной форме, способ его получения и используемые промежуточные продукты | |
US4894476A (en) | Gabapentin monohydrate and a process for producing the same | |
US5714607A (en) | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide | |
RU2000102914A (ru) | Кристаллическая модифицированная форма n-фенил-2-пиримидинаминового производного, способы ее получения и ее применение | |
Harris et al. | The synthesis of tenuazonic and congeneric tetramic acids | |
US4960931A (en) | Gabapentin mohohydrate and a process for producing the same | |
RU2128181C1 (ru) | 13-замещенные производные 5-оксима милбемицина, содержащая их антигельминтная, акарицидная и инсектицидная композиция | |
PL146571B1 (en) | Method of obtaining a mixture of volatile enantiomers of alpha-cyno-3-phenoxy-4-fluorobenzyl-permetrinic ester | |
HUP0202536A2 (hu) | A pravasztatin nátrium-sójának kristályai | |
US4319040A (en) | Process for the production of optically active threo-3-(3,4-dihydroxyphenyl)serine | |
DE3888236D1 (de) | Methode zur Kristallisation der Fruktose. | |
Jahngen Jr et al. | The synthesis of hadacidin: sodium cyanoborohydride reduction of α-oximinoic acids | |
DK143342B (da) | Cephalosporin-forbindelser til anvendelse som mellemprodukter ved fremstilling af cphalexon og fremgangsmaade til fremstilling af disse forbindelser | |
SU1282815A3 (ru) | Способ получени оптически активных транс-1Н-пропил-6-оксо-гидрохинолинов | |
US3329711A (en) | Phenylalanine compounds having alpha and beta quaternary carbon atoms | |
US3060192A (en) | Production of enantiomers of alphamethyl-phenethyl hydrazine and intermediate | |
Izumi et al. | The preparation of optically active α-C-substituted glutamic acid | |
US4283410A (en) | 3-Amino or amido-2-(1H-indol-3-yl) propanoic acid derivatives | |
Edelson et al. | Synthesis of 2-Cyclohexene-1-glycine and 1-Cyclohexene-1-alanine, Inhibitory Amino Acid Analogs | |
US3442909A (en) | Alpha-methyl-beta-(3,4-disubstitutedphenyl) propionitriles | |
FI103120B1 (fi) | Menetelmä laktitolin kiteyttämiseksi | |
SU222370A1 (ru) | Способ получения n-арилкарбамоилсиднониминов | |
Laliberte et al. | IMPROVED SYNTHESIS OF N-ALKYL-ASPARTIC ACIDS | |
US4283336A (en) | Process for the preparation of 3-amino-2-(5-fluoro and 5-methoxy-1H-indol-3-yl)propanoic acid derivatives | |
GB2023590A (en) | 3-amino-2-(5-fluoro and 5- methoxy-1H-indol-3-yl) Propanoic Acid Derivatives and Their Preparation and Use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |
|
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
MK4A | Patent expired |
Designated state(s): BY RU |